Licensing Deal Brings Sequenom's NIPD Technology to Parts of Europe, the Middle East, and Africa | GenomeWeb

NEW YORK (GenomeWeb News) – Sequenom announced today a deal to expand access to its MaterniT21 Plus fetal non-invasive prenatal diagnostic test to parts of Europe, the Middle East, and Africa.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.